80年代土耳其译制电影,80年代外国电影|80年代外国电影有哪些_80年代外国经典电影在线播放地址是多少？

[1]林生發(fā),彭英,蘇麗清,等.食管鱗癌表觀擴(kuò)散系數(shù)與分化程度、臨床分期相關(guān)性分析[J].福建醫(yī)藥雜志,2022,44(02):1-4.
　LIN Shengfa,PENG Ying,SU Liqing,et al.Correlation analysis of apparent diffusion coefficient with differentiation degree and clinical stage of esophageal squamous cell carcinoma[J].FUJIAN MEDICAL JOURNAL,2022,44(02):1-4.
點(diǎn)擊復(fù)制

食管鱗癌表觀擴(kuò)散系數(shù)與分化程度、臨床分期相關(guān)性分析()
分享到：

《福建醫(yī)藥雜志》[ISSN:1002-2600/CN:35-1071/R]

卷:
44
期數(shù):
2022年02期
頁碼:
1-4
欄目:
臨床研究
出版日期:
2022-04-15

文章信息/Info

Title:
Correlation analysis of apparent diffusion coefficient with differentiation degree and clinical stage of esophageal squamous cell carcinoma
文章編號:
1002-2600(2022)02-0001-04
作者:
林生發(fā); 彭英; 蘇麗清1; 沈衍富; 蘇家威; 馬明平2
福建醫(yī)科大學(xué)省立臨床醫(yī)學(xué)院 福建省立醫(yī)院放射科(福州 350001)
Author(s):
LIN Shengfa;  PENG Ying;  SU Liqing;  SHEN Yanfu;  SU Jiawei;  MA Mingping
Department of Radiology, Fujian Provincial Hospital,Provincial Clinical Medical College of Fujian Medical University, Fuzhou, Fujian 350001, China
關(guān)鍵詞:
食管鱗癌;  表觀擴(kuò)散系數(shù);  分化程度;  臨床分期
Keywords:
esophageal squamous cell carcinoma;  apparent diffusion coefficient;  degree of differentiation;  clinical stage
分類號:
R735.1; R445.2
文獻(xiàn)標(biāo)志碼:
B
摘要:
目的 探討食管鱗癌表觀擴(kuò)散系數(shù)值(apparent diffusion coefficient,ADC)與分化程度、臨床分期的相關(guān)性。方法 回顧性收集我院2019年5月至2020年7月手術(shù)證實(shí)為食管鱗癌的患者54例,所有病例均行磁共振成像(magnetic resonance imaging,MRI)常規(guī)序列檢查、精確頻率反轉(zhuǎn)恢復(fù)彌散加權(quán)成像(spectral presaturation attenuated inversion recovery-diffusion weighted imaging,SPAIR-DWI)檢查。由兩名影像科主治醫(yī)師分別在雙盲情況下測定ADC平均值,對食管鱗癌分化程度、臨床分期不同組間進(jìn)行單因素方差分析、多重比較法分析及相關(guān)性分析。結(jié)果 低、中、高分化組ADC平均值組間差異有統(tǒng)計學(xué)意義(F=30.91,P<0.01),高分化>中分化>低分化,呈正相關(guān)(r=0.76,P<0.01); Ⅰ-Ⅳ期平均ADC值組間差異有統(tǒng)計學(xué)意義(F=19.42,P<0.01),Ⅰ期>Ⅱ期>Ⅲ期>Ⅳ期,呈負(fù)相關(guān)(r=-0.71,P<0.01)。結(jié)論 ADC值與食管鱗癌分化程度呈正相關(guān),與臨床分期呈負(fù)相關(guān),能為臨床診療方案、預(yù)后評估等提供客觀影像依據(jù)。
Abstract:
Objective To explore the correlation between ADC value and differentiation degree and clinical stage of esophageal squamous cell carcinoma.Methods A total of 54 patients with esophageal squamous cell carcinoma confirmed by surgery in our hospital from May 2019 to July 2020 were collected retrospective, and all the cases underwent MRI routine sequence examination and SPIAR-DWI examination.Two attending radiologists measured the average ADC values under double-blind conditions, and performed univariate analysis of variance, multiple comparison analysis, and correlation analysis between the esophageal squamous cell carcinoma differentiation degree and clinical stage.Results The difference between the low, medium and high differentiated groups was statistically significant(F=30.91,P<0.01).The average ADC value: high differentiation> medium differentiation>low differentiation, which was positively correlated(r=0.76,P<0.01).There was a statistically significant difference between the groups in stage Ⅰ-Ⅳ(F=19.42,P<0.01).The average ADC value: stage Ⅰ> stage Ⅱ> stage Ⅲ> stage Ⅳ, which was negatively correlated(r=-0.71,P<0.01).Conclusion This study shows that ADC value is positively correlated with the degree of differentiation of esophageal squamous cell carcinoma, and negatively correlated with clinical staging.It can provide objective imaging basis for clinical diagnosis, treatment plan and prognosis evaluation.

參考文獻(xiàn)/References:

[1] Abnet C C, Arnold M, Wei W Q.Epidemiology of esophageal squamous cell carcinoma[J].Gastroenterology, 2018,154(2):360-373.
[2] Omloo J M,Lagarde S M,Hulscher J B,et al.Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial[J].Ann Surg,2007,246(6): 992-1000.
[3] Lei J,Han Q,Zhu S,et al.Assessment of esophageal carcinoma undergoing concurrent chemoradiotherapy with quantitative dynamiccontrast-enhanced magnetic resonanceimaging[J].OncolLett,2015,10(6): 3607-3612.
[4] Yang H, Liu H, Chen Y, et al.Neoadjuvant chemoradiotherapy followed by surgery versus surgeryalone for locally advanced squamous cell carcinoma of the esophagus(NEOCR-TEC5010): a phase Ⅲ multicenter, randomized, open-label clinical trial[J].J Clin Oncol,2018,36(27): 2796-2803.
[5] Leandri C, Soyer P,Oudjit A, et al.Contribution of magnetic resonance imaging to the management of esophageal diseases: a systematic review[J].European Journal of Radiology,2019(120):1-10.
[6] De Cobelli F,Palumbo D,Albarello L, et al.Esophagus and Stomach,is there a role for MR imaging?[J].Esophagus and Stomach,2020,28(1):1-15.
[7] Cong Q, Li G, Wang Y,et al.DW-MRI for esophageal squamous cell carcinoma, correlations between ADC values with histologic differentiation and VEGF expression: A retrospective study[J].Oncol Lett, 2019,17(3):2770-2776.
[8] Baliyan V, Das C J, Sharma R, et al.Diffusion weightedimaging:Technique and applications[J].World J Radiol, 2016, 8(9): 785.
[9] White N S, McDonald C R, Farid N, et al.Diffusion-weighted imaging in cancer: physical foundations and applications of restriction spectrum imaging[J].Cancer Res, 2014, 74(17): 4638-4652.
[10] Surov A,Meyer H J,Wienke A.Correlation between apparent diffusion coefficient(ADC)and cellularity is different in several tumors: a meta-analysis[J].Oncotarget 2007, 8(35):59492-59499.
[11] Hauge A,Wegner C S,Gaustad J V,et al.Diffusion-weighted MRI-derived ADC values reflect collagen I content in PDX models of uterine cervical cancer[J].Oncotarget,2017, 8(62):105682-105691.
[12] Hirata A,Hayano K,Ohira G,et al.volumetric histogram analysis of apparent diffusion coefficient as a biomarker to predict survival of esophageal cancer patients[J].AnnSurg Oncol,2020,27(8):3083-3089.
[13] Song T, Yao Q, Qu J,et al.The value of intravoxel incoherent motion diffusion-weighted imaging in predicting the pathologic response to neoadjuvant chemotherapy in locally advanced esophageal squamous cell carcinoma[J].EurRadiol, 2021,31(3):1391-1400.
[14] Liu G, Yang Z, Li T, Yang L,et al.Optimization of b-values in diffusion-weighted imaging for esophageal cancer: Measuring the longitudinal length of gross tumor volume and evaluating chemoradiotherapeutic efficacy[J].J Cancer Res Ther, 2017,13(5):748-755.
[15] 陳偉,王亞婷,柏根基,等.食管癌表觀擴(kuò)散系數(shù)值與病理預(yù)后因素的相關(guān)性分析[J].臨床放射學(xué)雜志,2020,39(3):476-480.
[16] 武東杰,侯亞靜.磁共振擴(kuò)散加權(quán)成像在食管癌顯示及惡性程度評估中的應(yīng)用[J].現(xiàn)代醫(yī)用影像學(xué),2017,26(4):955-959.

備注/Memo

備注/Memo:
1 福建省腫瘤醫(yī)院放診科; 2 通信作者,Email:[email protected]
更新日期/Last Update: 2022-04-15